Approval · Notice of Compliance 7260 · 2005
REACTINE ALLERGY & SINUS: Notice of Compliance 7260
Issued July 26, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7260
- Date
- July 26, 2005
- Company
- Pfizer Canada Inc., Consumer Healthcare DivisionMarkham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New claims: non-drowsy. lets you stay alert and perform normally. can be used while driving.
- Therapeutic class
- Histamine h1 receptor antagonist, sympathomimetic amine
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE ALLERGY & SINUS | Not yet assigned | — |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 5 MG per TAB
- PSEUDOEPHEDRINE HCL 120 MG per TAB